Tahoe Therapeutics
South San Francisco
About Tahoe Therapeutics
Tahoe Therapeutics develops AI-powered tools to simulate human cell responses and guide drug discovery. It operates a platform called Mosaic that produces large-scale single-cell datasets detailing how drug molecules interact with diverse patient cells, with initial applications in oncology. It open-sources its Tahoe-100M dataset, comprising hundreds of millions of single-cell profiles, to train AI models that build virtual cell models for therapeutic insights. A recent funding round enabled the creation of an even larger dataset, targeting one billion cell datapoints and one million drug-patient interactions, designed to fuel next-generation precision medicines
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $42.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: tahoebio.ai
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/tahoe-therapeutics-32618 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.